These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9829235)

  • 1. Proposition: positron imaging with SPECT and dual-head scintillation cameras obviates the need for PET in oncologic imaging.
    Madsen MT; Harkness BA
    Med Phys; 1998 Nov; 25(11):2116-8. PubMed ID: 9829235
    [No Abstract]   [Full Text] [Related]  

  • 2. New equipment in nuclear medicine, part 2: dual-head FDG coincidence detection cameras.
    Ketchum LE
    J Nucl Med; 1999 Mar; 40(3):9N-10N, 13N, 17N-18N passim. PubMed ID: 10086694
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of hybrid cameras in oncology.
    Delbeke D; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):268-80. PubMed ID: 11105928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
    Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
    Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-Fluorodeoxyglucose imaging in oncology.
    Harolds JA
    J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection.
    Kerrou K; Toussaint JF; Froissart M; Talbot JN
    J Nucl Med; 2000 Dec; 41(12):2099. PubMed ID: 11138698
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
    Bax JJ; Wijns W
    J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
    Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
    J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine: from photons to physiology.
    Bailey DL; Adamson KL
    Curr Pharm Des; 2003; 9(11):903-16. PubMed ID: 12678874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
    Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.
    Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
    Br J Radiol; 2002 May; 75(893):409-16. PubMed ID: 12036833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
    Delbeke D; Patton JA; Martin WH; Sandler MP
    J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
    Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
    J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.
    Andrieux A; Switsers O; Chajari MH; Jacob JH; Delozier T; Gervais R; Allouache N; Laurençon V; Henry-Amar M; Bardet S
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):68-77. PubMed ID: 16557206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is new in nuclear medicine imaging?
    Ferrand SK; Chen CC; Dilsizian V; Neumann RD
    Surg Oncol Clin N Am; 1999 Jan; 8(1):185-204. PubMed ID: 9824368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography.
    Seki R; Seki H; Toyama T; Koyama K; Endo K; Kurabayashi M
    J Cardiol; 2009 Apr; 53(2):265-71. PubMed ID: 19304132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation correction in hybrid positron emission tomography.
    Turkington TG
    Semin Nucl Med; 2000 Oct; 30(4):255-67. PubMed ID: 11105927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 20. Attenuation correction for cardiac dual-head gamma camera coincidence imaging using segmented myocardial perfusion SPECT.
    Fukuchi K; Sago M; Nitta K; Fukushima K; Toba M; Hayashida K; Takamiya M; Ishida Y
    J Nucl Med; 2000 May; 41(5):919-25. PubMed ID: 10809209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.